Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan.
Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
Intern Med. 2020 Dec 1;59(23):3015-3022. doi: 10.2169/internalmedicine.4977-20. Epub 2020 Aug 4.
We herein report four patients with desquamative esophagitis that developed one to nine days after peripheral blood stem cell transplantation (PBSCT). Three patients underwent allogeneic PBSCT for leukemia, and the other underwent autologous PBSCT for pineoblastoma. Esophagogastroduodenoscopy revealed mucosal sloughing and fresh blood in the esophagus. Fasting and intravenous proton pump inhibitor therapy in addition to blood transfusion improved the esophageal lesions within five to seven days in three patients. These cases indicate that desquamative esophagitis can occur in patients who receive hematopoietic stem cell transplantation. Although blood transfusions may be required, it can be resolved within seven days.
我们在此报告了 4 例在接受外周血干细胞移植(PBSCT)后 1 至 9 天发生剥脱性食管炎的患者。3 例患者接受异基因 PBSCT 治疗白血病,另 1 例患者接受自体 PBSCT 治疗松果体细胞瘤。食管胃十二指肠镜检查显示食管黏膜脱落和新鲜血液。3 例患者在禁食和静脉质子泵抑制剂治疗外加输血后,5 至 7 天内食管病变得到改善。这些病例表明,接受造血干细胞移植的患者可能会发生剥脱性食管炎。虽然可能需要输血,但可以在 7 天内解决。